INMD - InMode to Present at Upcoming Investor Conferences Before the End of 2022

PR Newswire

YOKNEAM, Israel , Nov. 1, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode will present at the following investor conferences in November:

13 ^th Annual Jefferies London Healthcare Conference
Presenters: Moshe Mizrahy , Chairman and Chief Executive Officer and Adrian Myrick , VP, Europe & Middle East
Format: In-person presentation and one-on-one meetings
Location: London, U.K.
When: Presentation scheduled for 10:20 a.m. GMT on Tuesday , November 15
A live webcast of the presentation can be accessed here .

2022 Canaccord Genuity MTDF Conference
Presenters: Moshe Mizrahy, Chairman and Chief Executive Officer, Yair Malca , Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer
Format: In-person presentation and one-on-one meetings
Location: NYC, U.S.
When: Presentation scheduled for 1:00 pm ET on Thursday , November 17
A live webcast of the presentation can be accessed here .

Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
Presenters: Yair Malca , Chief Financial Officer and Spero Theodorou MD, Chief Medical Officer
Format: In-person panel discussion and one-on-one meetings
Location: Miami Beach , U.S.
When: Panel scheduled for 1:45 pm ET on Thursday , December 8

About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com .

Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654

SOURCE InMode Ltd.